SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001178879-24-000013
Filing Date
2024-11-06
Accepted
2024-11-06 16:02:53
Documents
65
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q fold-20240930.htm   iXBRL 10-Q 1088227
2 EX-31.1 fold-09302024xex311.htm EX-31.1 11059
3 EX-31.2 fold-09302024xex312.htm EX-31.2 11135
4 EX-32.1 fold-09302024xex321.htm EX-32.1 8566
  Complete submission text file 0001178879-24-000013.txt   5788321

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT fold-20240930.xsd EX-101.SCH 32375
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT fold-20240930_cal.xml EX-101.CAL 64767
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT fold-20240930_def.xml EX-101.DEF 121438
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT fold-20240930_lab.xml EX-101.LAB 531755
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT fold-20240930_pre.xml EX-101.PRE 343683
68 EXTRACTED XBRL INSTANCE DOCUMENT fold-20240930_htm.xml XML 825759
Mailing Address 47 HULFISH STREET PRINCETON NJ 08542
Business Address 47 HULFISH STREET PRINCETON NJ 08542 (609) 662-2000
AMICUS THERAPEUTICS, INC. (Filer) CIK: 0001178879 (see all company filings)

IRS No.: 200422823 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33497 | Film No.: 241430812
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)